Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) — Board Meeting | 11 August 2026 (2 announcements)

Biofil Chemicals announced the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director despite reaching age 75, requiring shareholder approval via special resolution at the upcoming 41st AGM. The board approved his reappointment based on the Nomination and Remuneration Committee's recommendation, and the disclosure complies with SEBI LODR regulations and XBRL filing requirements.

Biofil Chemicals & Pharmaceuticals announced board approval of unaudited Q1 FY26 results showing revenue of ₹1,241.28 lakhs, up from ₹926.46 lakhs YoY, with net profit of ₹10.91 lakhs versus ₹241.10 lakhs previously, and scheduled its AGM for 23 September 2026; Mr. Ashok Kumar Ramawat was reappointed as Non-Executive Independent Director at age 75.